News
Gene Therapy for Dystrophic EB: Extension Study Results Reported
Patient-reported outcomes indicated that quality of life and satisfaction with treatment were preserved with continued treatment.
News
Positive Phase 2 Results Reported for TYK2 Inhibitor for Patients With Moderate to Severe Psoriasis
ESK-001 is also being evaluated in phase 2 studies of patients with systemic lupus erythematosus, and patients with non-infectious uveitis.
News
FDA warns about off-label use of laparoscopic device for aesthetic procedures
The agency has received reports describing “serious and potentially life-threatening adverse events with use of this device for certain aesthetic...
News
FDA updates status of iPLEDGE access problems
The Isotretinoin Products Manufacturers Group has “created a new tool within the system to help resolve account access for some user groups...
News
Abrocitinib approved for atopic dermatitis in Europe
Approval was based on the results of studies that include four phase 3 clinical trials and an ongoing open-label extension study.
News
European agency supports marketing of abrocitinib for atopic dermatitis
The JAK inhibitor is under review at the FDA for the same indication.
News
Dermatology News welcomes new advisory board member
Dr. Ionescu is a specialist in dermatology and venereology.
News
Rosacea: Target treatment to pathogenic pathway
LAHAINA, HAWAII – Papules and pustules, background erythema, telangiectasias, and phyma each need a tailored approach.
Video
Acne take home messages from the AAD annual meeting
WASHINGTON – “We want to treat sooner, and we want to prevent scarring.”
Video
Immunomodulators for pediatric skin diseases
WASHINGTON – Pediatric dermatologist A. Yasmine Kirkorian, MD, provides clinical pearls and practical considerations on the use of...
Video
SPD president discusses pediatric research, and more
WASHINGTON – The SPD now has more than 1,200 members and a research arm, the Pediatric Dermatology Research Alliance (PeDRA)...
Video
Climbing the therapeutic ladder in eczema-related itch
WASHINGTON – Oral medications include antihistamines, followed by “more intense”...
Video
VIDEO: Select atopic dermatitis patients need patch testing
In some cases, identifying the trigger for allergic contact dermatitis in a patient with AD can help avoid systemic therapy. ...